Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Holders of 5% or more of WVE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Wave Life Sciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13D/A | 13.40%25.5M shares | −1.20 ppfrom 14.60% | Nov 13, 20252 filings | Dec 15, 2025 | SEC |
| Adage Capital Management, L.P. | 13G/A | 9.65%15.0M shares | +1.50 ppfrom 8.15% | May 12, 20252 filings | Aug 12, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 6.10%9.36M shares | – | Feb 5, 20251 filing | Feb 5, 2025 | SEC |
| Maverick Capital LtdSuperinvestorMaverick Capital | 13G/A | 5.40%8.26M shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Wave Life Sciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 15, 20255:04 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 13.40%25.5M shares | −1.20 ppfrom 14.60% | Dec 11, 2025 | SEC |
| Nov 13, 20258:47 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 14.60%25.5M shares | – | Nov 11, 2025 | SEC |
| Aug 12, 20259:04 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 9.65%15.0M shares | +1.50 ppfrom 8.15% | Jun 30, 2025 | SEC |
| May 12, 20259:06 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 8.15%12.5M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20254:15 PM ET | Maverick Capital Ltdand 2 othersSuperinvestorMaverick Capital | 13G/A | 5.40%8.26M shares | – | Dec 31, 2024 | SEC |
| Feb 5, 20255:28 PM ET | BlackRock, Inc. | 13G/A | 6.10%9.36M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Wave Life Sciences, Inc. shares.
No Form 144 notices for Wave Life Sciences, Inc. are on file.